JPH06287158A - Indene derivative and antimicrobial agent with the same as active ingredient - Google Patents

Indene derivative and antimicrobial agent with the same as active ingredient

Info

Publication number
JPH06287158A
JPH06287158A JP9866993A JP9866993A JPH06287158A JP H06287158 A JPH06287158 A JP H06287158A JP 9866993 A JP9866993 A JP 9866993A JP 9866993 A JP9866993 A JP 9866993A JP H06287158 A JPH06287158 A JP H06287158A
Authority
JP
Japan
Prior art keywords
compound
antimicrobial agent
indene derivative
same
sprouts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9866993A
Other languages
Japanese (ja)
Other versions
JP2754312B2 (en
Inventor
Yukio Ishiguro
幸雄 石黒
Hirotsugu Sonoda
洋次 園田
Kenji Okamoto
賢治 岡本
Yoshimitsu Okamoto
誉充 岡本
Hideki Sakamoto
秀樹 坂本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kagome Co Ltd
Original Assignee
Kagome Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kagome Co Ltd filed Critical Kagome Co Ltd
Priority to JP9866993A priority Critical patent/JP2754312B2/en
Priority to EP94302155A priority patent/EP0618182B1/en
Priority to DE69401151T priority patent/DE69401151D1/en
Publication of JPH06287158A publication Critical patent/JPH06287158A/en
Priority to US08/372,729 priority patent/US5534546A/en
Application granted granted Critical
Publication of JP2754312B2 publication Critical patent/JP2754312B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PURPOSE:To provide a new compound giving excellent antimicrobial activity on bacteria, yeast and fungi, thus useful as an antimicrobial agent. CONSTITUTION:The compound, 3,5-dimethoxy-1H-inden-1-one of the formula. This compound can be obtained by the following process: adlay seeds are cultured in the dark at 25 deg.C for 4 to 8 days to produce adlay sprouts, and the adlay sprouts, a ground product thereof, or lyophilized product thereof, are put to extraction followed by chromatographic fractionation. The molecular weight and molecular formula of this compound are 190 and C11H10O3, respectively. This compound can be used, as a natural antimicrobial agent, in foods, cosmetics, etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はインデン誘導体及びこれ
を有効成分とする抗菌剤に関する。
TECHNICAL FIELD The present invention relates to an indene derivative and an antibacterial agent containing the same as an active ingredient.

【0002】[0002]

【従来の技術】ハトムギもやしの乾燥物、搾汁液又は抽
出物に抗菌活性のあることが知られており、かかる抗菌
活性を示す化合物としてステアリン酸又はパルミチン酸
のモノグリセライド、又はこれらの誘導体が示唆されて
いる(特開平2−270825、特開平3−24047
3)。
2. Description of the Related Art It is known that dried products, juices or extracts of coix sprouts have antibacterial activity, and monoglycerides of stearic acid or palmitic acid, or derivatives thereof are suggested as compounds exhibiting such antibacterial activity. (JP-A-2-270825, JP-A-3-24047)
3).

【0003】[0003]

【発明が解決しようとする課題】本発明は、ハトムギも
やしから単離され、優れた抗菌活性を示す、新規のイン
デン誘導体を提供するものである。
DISCLOSURE OF THE INVENTION The present invention provides a novel indene derivative isolated from adlay bean sprouts and showing excellent antibacterial activity.

【0004】[0004]

【課題を解決するための手段】しかして本発明者らは、
ハトムギもやしの乾燥物、搾汁液又は抽出物が示す抗菌
活性について鋭意研究した結果、ハトムギもやしに所定
の処理を施すと、新規のインデン誘導体が単離され、該
インデン誘導体が優れた抗菌活性を示すことを見出し
た。
However, the present inventors have
As a result of diligent research on the antibacterial activity of dried products, squeezed juices and extracts of coix sprouts, a new indene derivative was isolated when the bean sprouts were subjected to a predetermined treatment and the indene derivative showed excellent antibacterial activity. I found that.

【0005】すなわち本発明は、下記の式1で示される
インデン誘導体及びこれを有効成分とする抗菌剤に係
る。
That is, the present invention relates to an indene derivative represented by the following formula 1 and an antibacterial agent containing the same as an active ingredient.

【0006】[0006]

【式1】 [Formula 1]

【0007】式1で示されるインデン誘導体はハトムギ
もやしを次のように処理することによって単離される。
先ず、詳しくは実施例で後述するように、ハトムギ種子
を暗培養してハトムギもやしを得る。対象となるハトム
ギ種子は、徳田在来種、中里在来種、岡山在来種、黒石
在来種等、その品種に特に制限はない。また暗培養は一
般のもやし暗培養条件にしたがうことができる。例え
ば、ハトムギ種子を25℃で4〜8日間程度暗培養すれ
ばよい。かくして得られるハトムギもやしはその全部位
を利用することができる。
The indene derivative represented by the formula 1 is isolated by treating pearl barley sprouts as follows.
First, as described later in detail in Examples, pearl barley seeds are subjected to dark culture to obtain pearl barley sprouts. The target pearl barley seeds are not particularly limited in their variety such as Tokuda native species, Nakazato native species, Okayama native species, and Kuroishi native species. In addition, the dark culture can be performed according to general bean sprouts dark culture conditions. For example, adlay seeds may be subjected to dark culture at 25 ° C. for about 4 to 8 days. The thus obtained pearl barley sprouts can be used for all parts thereof.

【0008】次に、これも詳しくは実施例で後述するよ
うに、上記のハトムギもやし、その磨砕物、凍結乾燥
物、更には粉砕物等をメチルアルコールやエチルアルコ
ール等の低級アルコールで抽出処理し、その抽出物をク
ロロホルムやアセトン等で液液分配抽出処理して、アセ
トン易溶性の単純脂質を得る。
As will be described later in more detail in the Examples, the above-mentioned bean sprouts, ground products, freeze-dried products, and further pulverized products are extracted with a lower alcohol such as methyl alcohol or ethyl alcohol. Then, the extract is subjected to a liquid-liquid partition extraction process with chloroform, acetone or the like to obtain a simple lipid easily soluble in acetone.

【0009】最後に、これもまた詳しくは実施例で後述
するように、上記の単純脂質を繰り返してクロマト分画
処理し、所望の化合物を単離する。クロマト分画処理
は、極性の異なる移動相を用い、ゲル浸透クロマトグラ
フィーと高速液体クロマトグラフィーとを組み合わせて
行うのが好ましい。
Finally, this is repeated chromatographic fractionation of the simple lipids described above, again as described in more detail in the Examples, to isolate the desired compound. The chromatographic fractionation treatment is preferably carried out by using mobile phases having different polarities and combining gel permeation chromatography and high performance liquid chromatography.

【0010】かくして単離される化合物の構造解析結果
は下記の通りである。 (1)分子量:190(C11103) (2)赤外線吸収スペクトル:1585,1703,3
050cm-1 (3)核磁気共鳴スペクトル(1H−NMR,δ):
3.99(3H,s),4.09(3H,s),5.9
8(1H,s),7.19(1H,dd,J=8.7
9,2.56),7.56(1H,d,J=2.5
6),8.00(1H,d,J=8.79) (4)核磁気共鳴スペクトル(13C−NMR,δ):5
7.7,58.7,105.6,112.3,118.
1,126.1,133.2,136.6,167.
2,169.3,181.5
The structural analysis results of the compound thus isolated are as follows. (1) Molecular weight: 190 (C 11 H 10 O 3 ) (2) Infrared absorption spectrum: 1585, 1703, 3
050 cm −1 (3) Nuclear magnetic resonance spectrum ( 1 H-NMR, δ):
3.99 (3H, s), 4.09 (3H, s), 5.9
8 (1H, s), 7.19 (1H, dd, J = 8.7)
9, 2.56), 7.56 (1H, d, J = 2.5
6), 8.00 (1H, d, J = 8.79) (4) Nuclear magnetic resonance spectrum ( 13 C-NMR, δ): 5
7.7, 58.7, 105.6, 112.3, 118.
1, 126.1, 133.2, 136.6, 167.
2,169.3,181.5

【0011】上記の構造解析結果から、単離される化合
物は式1で示されるインデン誘導体であり、3,5−ジ
メトキシ−1H−インデン−1−オンであることが決定
された。
From the above structural analysis results, it was determined that the isolated compound was the indene derivative represented by the formula 1, and was 3,5-dimethoxy-1H-inden-1-one.

【0012】詳しくは実施例で後述するように、式1で
示されるインデン誘導体は、細菌、酵母、カビに対して
優れた抗菌活性を示し、天然抗菌剤として食品や化粧品
等への利用が注目される。
[0012] As will be described later in detail in the Examples, the indene derivative represented by the formula 1 exhibits excellent antibacterial activity against bacteria, yeasts and molds, and its use as a natural antibacterial agent in foods, cosmetics and the like is noted. To be done.

【0013】[0013]

【実施例】【Example】

試験区分1(インデン誘導体の単離) 収穫した徳田在来種のハトムギ種子を25℃で4日間暗
培養してハトムギもやしを得、該ハトムギもやしを磨砕
した後に棚温度20℃で凍結乾燥して、凍結乾燥物を得
た。
Test Category 1 (Isolation of Indene Derivatives) The harvested Tokuda native pearl barley seeds were subjected to dark culture at 25 ° C. for 4 days to obtain pearl barley sprouts, which were then lyophilized at a shelf temperature of 20 ° C. A lyophilized product was obtained.

【0014】上記の凍結乾燥物150gにメチルアルコ
ール6リットルを加え、ホモジナイズ処理し、これを室
温で48時間放置した後、濾過して抽出液を得た。残渣
にメチルアルコール6リットルを加え、同様に抽出処理
を行なって抽出液を得、これを1回目の抽出液と合わせ
た。そして合わせた抽出液を減圧下に40〜45℃で加
熱してメチルアルコールを蒸発することにより抽出物3
0gを得た。
To 150 g of the above freeze-dried product, 6 liters of methyl alcohol was added and homogenized, and this was left at room temperature for 48 hours and then filtered to obtain an extract. Methyl alcohol (6 liters) was added to the residue and the same extraction treatment was performed to obtain an extract, which was combined with the first extract. Then, the combined extract was heated at 40 to 45 ° C. under reduced pressure to evaporate the methyl alcohol and thereby extract 3
0 g was obtained.

【0015】上記の抽出物30gにメチルアルコール1
00mlとクロロホルム200mlとを加え、混合撹拌し、
更に0.8%塩化カリウム水溶液60mlを加えて静置し
た。クロロホルム層を分取し、減圧下に40〜45℃で
加熱して1mlに濃縮した後、アセトン10mlと10%メ
チルアルコール性塩化マグネシウム溶液0.2mlとを加
え、混合撹拌し、1時間氷冷後、遠心分離して、上清の
アセトン溶液を分取した。残渣にアセトン10mlと10
%メチルアルコール性塩化マグネシウム溶液0.2mlと
を加え、同様に処理を行なって、アセトン溶液を得、こ
れを1回目のアセトン溶液と合わせた。そして合わせた
アセトン溶液を減圧下に40〜45℃で加熱してアセト
ンを蒸発することによりアセトン易溶性の単純脂質7.
1gを分離した。
1 g of methyl alcohol was added to 30 g of the above extract.
00 ml and chloroform 200 ml were added, mixed and stirred,
Further, 60 ml of 0.8% aqueous potassium chloride solution was added and the mixture was allowed to stand. The chloroform layer was separated, heated under reduced pressure at 40-45 ° C. and concentrated to 1 ml, then 10 ml of acetone and 0.2 ml of 10% methyl alcoholic magnesium chloride solution were added, mixed and stirred, and ice-cooled for 1 hour. Then, the mixture was centrifuged to separate the supernatant acetone solution. 10 ml of acetone and 10 to the residue
% Methyl alcoholic magnesium chloride solution (0.2 ml) was added, and the same treatment was carried out to obtain an acetone solution, which was combined with the first acetone solution. Then, the combined acetone solution is heated under reduced pressure at 40 to 45 ° C. to evaporate the acetone, and thus the simple lipid easily soluble in acetone 7.
1 g was separated.

【0016】上記の単純脂質7.1gをクロロホルムで
溶解し、ジャイゲル 1H(JAIGEL 1H、商品
名、日本分析工業社製、8.0mmφ×500mm)を2本
用いてゲル浸透クロマトグラフィーを行なった。この
際、移動相としてクロロホルムを用い、該クロロホルム
を流速3.5ml/分で流下させた。RI(屈折率)で検
出し、主要なピークを示す4画分を得た。バチルス サ
ブチリス、サッカロミセス セレビシェ、アスペルギル
ス ニガーを検定菌として、各画分の抗菌試験をペーパ
ーディスク法により行ない、最も強い抗菌活性を示すR
t(保持時間、以下同じ)=55〜64分の画分1.8
gを得た。
7.1 g of the above-mentioned simple lipid was dissolved in chloroform, and gel permeation chromatography was carried out using 2 pieces of Jaigel 1H (JAIGEL 1H, trade name, manufactured by Nippon Analytical Industry Co., Ltd., 8.0 mmφ × 500 mm). At this time, chloroform was used as a mobile phase, and the chloroform was allowed to flow down at a flow rate of 3.5 ml / min. Detected by RI (refractive index), 4 fractions showing major peaks were obtained. Using the Bacillus subtilis, Saccharomyces cerevisiae, and Aspergillus niger as test bacteria, antibacterial tests of each fraction were performed by the paper disk method, and R showing the strongest antibacterial activity was obtained.
t (holding time, the same applies hereinafter) = fraction 1.8 of 55 to 64 minutes
g was obtained.

【0017】上記の画分1.8gをメチルアルコールで
溶解し、キャップセル パックC18(CAPCELL
PAK C18、商品名、資生堂社製、20mmφ×250
mm、以下同じ)を用いて高速液体クロマトグラフィーを
行なった。この際、移動相としてメチルアルコール/水
=20/80(重量比)で出発し、30分後に100/
0(重量比)となる直線グラジエントを行ない、該移動
相を流速3.0ml/分で流下させた。UV(紫外線吸光
度、254nm、以下同じ)で検出し、主要なピークを
示す6画分を得た。上記と同様の抗菌試験により、最も
強い抗菌活性を示すRt=34〜38分の画分146.
4mgを得た。
1.8 g of the above-mentioned fraction was dissolved in methyl alcohol to obtain Capcell Pack C 18 (CAPCELL).
PAK C 18 , product name, Shiseido Co., 20mmφ × 250
mm, hereinafter the same) was used to perform high performance liquid chromatography. At this time, the mobile phase started with methyl alcohol / water = 20/80 (weight ratio), and after 30 minutes, 100 /
A linear gradient of 0 (weight ratio) was performed, and the mobile phase was allowed to flow down at a flow rate of 3.0 ml / min. It was detected by UV (ultraviolet absorbance, 254 nm, the same applies hereinafter), and 6 fractions showing major peaks were obtained. By the same antibacterial test as described above, the fraction 146.
4 mg was obtained.

【0018】上記の画分146.4mgをメチルアルコー
ルで溶解し、キャップセル パックC18を用いて高速液
体クロマトグラフィーを行なった。この際、移動相とし
てメチルアルコール/水=50/50(重量比)を用
い、該移動相を流速3.0ml/分で流下させた。UVで
検出し、主要なピークを示す8画分を得た。上記と同様
の抗菌試験により、検定菌全てに強い抗菌活性を示すR
t=45分の化合物12.8mgを単離した。
146.4 mg of the above-mentioned fraction was dissolved in methyl alcohol and subjected to high performance liquid chromatography using Capcell Pack C 18 . At this time, methyl alcohol / water = 50/50 (weight ratio) was used as the mobile phase, and the mobile phase was allowed to flow down at a flow rate of 3.0 ml / min. By UV detection, 8 fractions showing major peaks were obtained. R showing strong antibacterial activity against all test bacteria by the same antibacterial test
12.8 mg of the compound at t = 45 minutes are isolated.

【0019】かくして単離した化合物の構造解析結果は
前述した通りであり、該化合物は式1で示される3,5
−ジメトキシ−1H−インデン−1−オンであった。
The structural analysis results of the compound thus isolated are as described above, and the compound is represented by the formula 1,3,5
It was -dimethoxy-1H-inden-1-one.

【0020】試験区分2(インデン誘導体の抗菌活性) 抗菌活性は、バチルス サブチリス、サッカロミセス
セレビシェ、アスペルギルス ニガーを検定菌として、
ペーパーディスク法で試験した。バチルス サブチリス
は下記のトリプトソイ寒天培地(寒天1.5%)を、ま
たサッカロミセス セレビシェ及びアスペルギルス ニ
ガーは下記のポテトデキストロース寒天培地(寒天1.
5%)をそれぞれ使用し、これらの寒天培地15mlを径
90mmのシャーレに注入固化して、平板培地を作製し
た。 トリプトソイ寒天培地(日水製薬社製) ペプトン1.5%、ダイズペプトン0.5%、NaCl
0.5%及び寒天1.5% ポテトデキストロース寒天培地(日水製薬社製) ポテト浸出液末0.4%、ブドウ糖2.0%及び寒天
1.5%
Test Category 2 (antibacterial activity of indene derivative) Antibacterial activity is Bacillus subtilis, Saccharomyces
Cereviche and Aspergillus niger as test bacteria,
It was tested by the paper disc method. Bacillus subtilis uses the following tryptosoy agar (1.5% agar), and Saccharomyces cerevisiae and Aspergillus niger use the following potato dextrose agar (agar 1.
5%) were used, and 15 ml of these agar mediums were injected into a petri dish having a diameter of 90 mm and solidified to prepare a plate medium. Trypto Soy Agar (Nissui Pharmaceutical Co., Ltd.) Peptone 1.5%, Soybean peptone 0.5%, NaCl
0.5% and agar 1.5% Potato dextrose agar (manufactured by Nissui Pharmaceutical Co., Ltd.) Potato infusion liquid 0.4%, glucose 2.0% and agar 1.5%

【0021】検定菌を上記と同様の寒天培地15mlに接
種し、これを上記平板培地上に重層して固化した。重層
した平板培地上にペーパーディスク(東洋濾紙、径8m
m、薄手)を置き、該ペーパーディスクに単離した化合
物(10mg/ml)を20μl滴下し(200μg/ペーパ
ーディスク)、バチルス サブチリスは24時間培養
後、またサッカロミセス セレビシェ及びアスペルギル
ス ニガーは48時間培養後、生育阻止円の直径をそれ
ぞれ測定した。ペーパーディスク5枚の平均値をとり、
下記の式2により抗菌活性を求めた。
The test strain was inoculated into 15 ml of the same agar medium as described above, and this was layered on the above plate medium and solidified. Paper disk (Toyo filter paper, diameter 8m)
20 μl of the isolated compound (10 mg / ml) was dropped onto the paper disc (200 μg / paper disc), Bacillus subtilis was cultured for 24 hours, and Saccharomyces cerevisiae and Aspergillus niger were cultured for 48 hours. The diameter of the growth inhibition circle was measured. Take the average of 5 paper disks,
The antibacterial activity was determined by the following formula 2.

【式2】抗菌活性(mm)=阻止円の直径(mm)−ペーパ
ーディスクの直径(8mm)
[Formula 2] Antibacterial activity (mm) = diameter of blocking circle (mm) -diameter of paper disc (8 mm)

【0022】抗菌活性は、バチルス サブチリスに対し
て20.0mm、サッカロミセス セレビシェに対して1
1.5mm、アスペルギルス ニガーに対して11.5mm
であり、単離した化合物はこれらの細菌、酵母、カビに
対して優れた抗菌活性を示すことが検定された。
The antibacterial activity was 20.0 mm against Bacillus subtilis and 1 against Saccharomyces cerevisiae.
1.5mm, 11.5mm against Aspergillus niger
The isolated compound was assayed to show excellent antibacterial activity against these bacteria, yeasts and molds.

【0023】[0023]

【発明の効果】既に明らかなように、以上説明した本発
明のインデン誘導体には抗菌剤として有効という効果が
ある。
As is apparent from the above, the indene derivative of the present invention described above is effective as an antibacterial agent.

フロントページの続き (72)発明者 岡本 賢治 栃木県那須郡西那須野町西富山47番地 カ ゴメ那須寮311号 (72)発明者 岡本 誉充 栃木県那須郡西那須野町西富山47番地 カ ゴメ那須寮315号 (72)発明者 坂本 秀樹 栃木県那須郡西那須野町大字井口字腰巻47 番地12Front page continuation (72) Kenji Okamoto 47-3 Nishitomiyama, Nishinasuno-machi, Nasu-gun, Tochigi Prefecture Kagome Nasu Dormitory No. 311 (72) Inventor Takamitsu 47, Nishitoyama, Nishinasuno-cho, Nasu-gun, Tochigi Prefecture Kagome Nasu Dormitory No. 315 (72) Inventor Hideki Sakamoto 47, 12 Koshimaki, Iguchi, Nishinasuno-cho, Nasu-gun, Tochigi

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 下記の式1で示されるインデン誘導体。 【式1】 1. An indene derivative represented by the following formula 1. [Formula 1] 【請求項2】 請求項1記載のインデン誘導体を有効成
分とする抗菌剤。
2. An antibacterial agent containing the indene derivative according to claim 1 as an active ingredient.
JP9866993A 1993-03-31 1993-03-31 Indene derivative and antibacterial agent containing the same as an active ingredient Expired - Lifetime JP2754312B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP9866993A JP2754312B2 (en) 1993-03-31 1993-03-31 Indene derivative and antibacterial agent containing the same as an active ingredient
EP94302155A EP0618182B1 (en) 1993-03-31 1994-03-25 Indene derivatives and antimicrobial agents containing them
DE69401151T DE69401151D1 (en) 1993-03-31 1994-03-25 Indene derivatives and antimicrobial agents containing these indene derivatives as active components
US08/372,729 US5534546A (en) 1993-03-31 1995-01-17 Indene derivatives and antimicrobial agents containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9866993A JP2754312B2 (en) 1993-03-31 1993-03-31 Indene derivative and antibacterial agent containing the same as an active ingredient

Publications (2)

Publication Number Publication Date
JPH06287158A true JPH06287158A (en) 1994-10-11
JP2754312B2 JP2754312B2 (en) 1998-05-20

Family

ID=14225927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9866993A Expired - Lifetime JP2754312B2 (en) 1993-03-31 1993-03-31 Indene derivative and antibacterial agent containing the same as an active ingredient

Country Status (1)

Country Link
JP (1) JP2754312B2 (en)

Also Published As

Publication number Publication date
JP2754312B2 (en) 1998-05-20

Similar Documents

Publication Publication Date Title
Marotti et al. Effects of variety and ontogenic stage on the essential oil composition and biological activity of fennel (Foeniculum vulgare Mill.)
AU2007217003B2 (en) Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production
JPH0222755B2 (en)
CN101454015A (en) Extracts and methods comprising green tea species
Vargas-Arispuro et al. Antifungal lignans from the creosotebush (Larrea tridentata)
KR100486763B1 (en) Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof
US11484490B2 (en) Skin external composition containing an extract of a fermented product of red yeast rice
KR101717020B1 (en) The composition comprising saponins derived from green tea seed having antifungal and anticancer activity and manufacturing method thereof
JP6369751B2 (en) Curcumin derivative exhibiting keratin producing action and method for producing the same
US5534546A (en) Indene derivatives and antimicrobial agents containing same
JP2754313B2 (en) Indene derivative and antibacterial agent containing the same as an active ingredient
JPH06287158A (en) Indene derivative and antimicrobial agent with the same as active ingredient
KR102530981B1 (en) A cosmetic composition for promoting skin beneficial bacteria
JPH0640876A (en) External preparation for shielding human health from adverse effect due to ultraviolet light
EP3620212B1 (en) Fermented violet extract, method for obtaining such an extract and use in cosmetics
JPH09110712A (en) Camellia sinensis l. saponin antifungal agent
JPH09241104A (en) Antimicrobial agent containing naphthoquinone derivative as effective component
JPH01283227A (en) Antimutagen agent
EP3299448B1 (en) Yeast strain and production method of natural cinnamic acid using fermentation thereof
KR102329297B1 (en) Cosmetic composition for anti-inflammatory or anti-atopic comprising fermented permission leaf extract
KR102530034B1 (en) Method for preparing purified snake venom with inactivated toxic components
JP2772552B2 (en) Preventive agent for dental caries and periodontal disease
JPH06345658A (en) Antibacterial agent
JPH0859407A (en) Antimicrobial agent
JPH0398562A (en) Beverage composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 10

Free format text: PAYMENT UNTIL: 20080306

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090306

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20100306

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 13

Free format text: PAYMENT UNTIL: 20110306

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 13

Free format text: PAYMENT UNTIL: 20110306

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 14

Free format text: PAYMENT UNTIL: 20120306

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 14

Free format text: PAYMENT UNTIL: 20120306

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 15

Free format text: PAYMENT UNTIL: 20130306